Td Asset Management Inc Invitae Corp Transaction History

Td Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$6.28 - $15.59 $476,469 - $1.18 Million	-75,871 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $670,159 - $1.15 Million	20,271 Added 36.46%	75,871 $2.9 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $973,341 - $1.43 Million	24,900 Added 81.11%	55,600 $2.33 Million
Q3 2020 Nov 10, 2020	BUY	$28.43 - $44.67 $136,464 - $214,416	4,800 Added 18.53%	30,700 $1.33 Million
Q2 2020 Aug 13, 2020	BUY	$11.71 - $30.29 $303,289 - $784,511	25,900 New	25,900 $785,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.